SXTP 60 Degrees Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases... Show more
SXTP is expected to report earnings to rise 5.47% to -135 cents per share on August 19
Q2'26
Est.
$-1.35
Q1'26
Beat
by $0.10
Q4'25
Missed
by $1.61
Q3'25
Missed
by $0.59
Q2'25
Missed
by $1.06
The last earnings report on May 14 showed earnings per share of -127 cents, beating the estimate of -137 cents. With 44.79K shares outstanding, the current market capitalization sits at 4.49M.
A.I.dvisor tells us that SXTP and OCGN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and OCGN's prices will move in lockstep.
SXTP in upward trend: price rose above 50-day moving average on June 17, 2026
SXTP moved above its 50-day moving average on June 17, 2026 date and that indicates a change from a downward trend to an upward trend. In of 17 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 17, 2026. You may want to consider a long position or call options on SXTP as a result. In of 41 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for SXTP just turned positive on May 21, 2026. Looking at past instances where SXTP's MACD turned positive, the stock continued to rise in of 18 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTP advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
SXTP broke above its upper Bollinger Band on June 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SXTP entered a downward trend on June 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SXTP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (20.966). P/E Ratio (14.571) is within average values for comparable stocks, (36.007). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.690). SXTP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (4.439) is also within normal values, averaging (367.026).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
